Celecoxib-induced acute generalized exanthematous pustulosis
Celecoxib, a selective COX-2 inhibitor, and non-selective anti-inflammatory drug, is commonly prescribed as the first-line analgesic for osteoarthritis, rheumatoid arthritis, and certain acute pain cases. It is mainly preferred for its lower risk of gastrointestinal adverse effects. However, it also...
| Published in: | EXCLI Journal : Experimental and Clinical Sciences |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund
2024-01-01
|
| Subjects: | |
| Online Access: | https://www.excli.de/index.php/excli/article/view/6809 |
